Eli Lilly & Co.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2025
Total Assets: $112.48B
Liabilities Breakdown FY2025
Total Liabilities: $85.94B
Asset Breakdown
Total Assets: $112.48B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $7.27B | 6.5% |
| Accounts Receivable | $17.76B | 15.8% |
| Inventory | $13.74B | 12.2% |
| Property, Plant & Equipment | $24.68B | 21.9% |
| Goodwill | $5.90B | 5.2% |
| Intangible Assets | $6.52B | 5.8% |
| Other Assets | $36.61B | 32.5% |
Liabilities Breakdown
Total Liabilities: $85.94B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.38B | 6.3% |
| Long-Term Debt | $40.87B | 47.6% |
| Other Liabilities | $39.69B | 46.2% |